INS and Insulin resistance: Serum insulin was significantly higher in mice injected at ZT23 particularly during the dark phase (Fig. 5d, Supplementary Fig. S5d), indicating insulin resistance in these mice, although NAD+ therapy was effective to reduce fasting serum glucose independently of the time of supply (Supplementary Fig. S5e).